These studies have shown that long-term use of NSAIDs is associated with a reduced risk of AD and that some NSAIDs can reduce the levels of phosphorylated tau protein, improve cognitive function, and suppress the activation of microglia. Here, MAPT is linked to Alzheimer disease.